Direkt zum Inhalt
Merck
  • New co-processed MCC-based excipient for fast release of low solubility drugs from pellets prepared by extrusion-spheronization.

New co-processed MCC-based excipient for fast release of low solubility drugs from pellets prepared by extrusion-spheronization.

Drug development and industrial pharmacy (2013-11-28)
Alvaro Goyanes, Ramón Martínez-Pacheco
ZUSAMMENFASSUNG

In this study, a new co-processed excipient composed of microcrystalline cellulose (MCC), sorbitol, chitosan and Eudragit® E, easily obtained by wet massing, to increase the dissolution rate of active ingredients of low water solubility from pellets prepared by extrusion-spheronization is evaluated. Indomethacin, nifedipine, furosemide, ibuprofen, prednisolone and hydrochlorothiazide are used as model drugs of different solubility. All pellet formulations evaluated showed adequate morphological, flow and mechanical properties. Pellets prepared with the co-processed excipient show a higher drug dissolution rate than those prepared with MCC and even higher than the pure drug powder. The fast drug dissolution and the complete disintegration (<3 min) of the pellets can be explained by the great porosity of the formulations, the high solubility of the sorbitol, the disintegrant capacity of the chitosan and the distribution of the Eudragit® E polymer particles in-between the other components of the co-processed mixture. In conclusion, this new co-processed excipient is very suitable to increase the dissolution rate of poorly soluble drugs from pellets prepared by extrusion-spheronization. Moreover, the drug release rate can be estimated from the Ln of the drug solubility in acidic medium.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Salzsäure, ACS reagent, 37%
Sigma-Aldrich
Salzsäure, ACS reagent, 37%
Sigma-Aldrich
Chlorwasserstoff -Lösung, 4.0 M in dioxane
Sigma-Aldrich
D-Sorbit, ≥98% (GC)
Sigma-Aldrich
Salzsäure -Lösung, 1.0 N, BioReagent, suitable for cell culture
Sigma-Aldrich
Salzsäure, meets analytical specification of Ph. Eur., BP, NF, fuming, 36.5-38%
Sigma-Aldrich
Salzsäure, 37 wt. % in H2O, 99.999% trace metals basis
Sigma-Aldrich
Salzsäure, 36.5-38.0%, BioReagent, for molecular biology
Sigma-Aldrich
Chlorwasserstoff -Lösung, 2.0 M in diethyl ether
Supelco
Salzsäure -Lösung, volumetric, 0.1 M HCl (0.1N), endotoxin free
Sigma-Aldrich
D-Sorbit, BioUltra, ≥99.0% (HPLC)
Sigma-Aldrich
D-Sorbit, 99% (GC)
Sigma-Aldrich
D-Sorbit, ≥98% (GC), for molecular biology
Sigma-Aldrich
Chlorwasserstoff -Lösung, 1.0 M in diethyl ether
Sigma-Aldrich
Chlorwasserstoff, ReagentPlus®, ≥99%
USP
Sorbit, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Salzsäure -Lösung, ~6 M in H2O, for amino acid analysis
Sigma-Aldrich
D-Sorbit, ≥98% (GC), BioReagent, suitable for cell culture, suitable for plant cell culture
Sigma-Aldrich
Chlorwasserstoff -Lösung, 3 M in cyclopentyl methyl ether (CPME)
Sigma-Aldrich
Salzsäure -Lösung, 32 wt. % in H2O, FCC
Sigma-Aldrich
Sorbit F -Lösung, 70 wt. % in H2O, Contains mainly D-sorbitol with lesser amounts of other hydrogenated oligosaccharides
Sigma-Aldrich
D-Sorbit, FCC, FG
Sigma-Aldrich
Chlorwasserstoff -Lösung, 1.0 M in acetic acid
Sigma-Aldrich
D-Sorbit, ≥98% (GC), BioXtra
Supelco
Sorbit, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Chlorwasserstoff – Methanol -Lösung, ~1.25 m HCl (T), for GC derivatization, LiChropur
Supelco
Salzsäure – Ethanol -Lösung, ~1.25 M HCl, for GC derivatization, LiChropur
Supelco
Chlorwasserstoff–2-Propanol -Lösung, ~1.25 M HCl (T), for GC derivatization, LiChropur
Sorbit, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
D-Sorbit, liquid, tested according to Ph. Eur.